KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Mar 15, 2017
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-02-14+97,500→ 97,500 totalExercise: $5.53From: 2018-02-14Exp: 2027-02-14→ Common Stock (97,500 underlying) - Award
Common Stock
2017-02-14+48,750→ 147,623 total
Footnotes (3)
- [F1]The 48,750 shares are restricted common stock, with one-third of the 48,750 shares vesting on February 14, 2018 and one-twelfth vesting on each of May 14, 2018, August 14, 2018, November 14, 2018, February 14, 2019, May 14, 2019, August 14, 2019, November 14, 2019 and February 14, 2020.
- [F2]Includes 107,080 shares of restricted stock.
- [F3]The options vest according to the following schedule: one-third of the 97,500 options will vest on February 14, 2018 and one-twelfth will vest on each of May 14, 2018, August 14, 2018, November 14, 2018, February 14, 2019, May 14, 2019, August 14, 2019, November 14, 2019 and February 14, 2020.